Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Other: diagnostic laboratory biomarker analysis; Drug: ixabepiloneSponsor: National Cancer Institute (NCI)Suspended - verified December 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chemotherapy | Leiomyosarcoma | Research | Sarcomas | Uterine Sarcoma